Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Temple

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinical Trials (London, England)|October 7, 2011
A regulator's view of comparative effectiveness researchRobert Temple
Accountability in Research|January 1, 1996
Problems in interpreting active control equivalence trialsRobert Temple
Biomarkers in Medicine|May 19, 2010
Complexities in drug trials: enrichment, biomarkers and surrogates. Interview with Robert TempleRobert Temple
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Cancer chemoprevention--the cardiovascular modelRobert Temple
Statistics in Medicine|September 27, 2002
Policy developments in regulatory approvalRobert Temple
Molecular Interventions|December 24, 2004
ROBERT TEMPLE: an eye for data. InterviewRobert Temple
Clinical Trials (London, England)|November 12, 2005
How FDA currently makes decisions on clinical studiesRobert Temple
Pharmaceutical Statistics|August 27, 2021
Encouragement of subgroup assessment by the FDARobert Temple
Statistics in Medicine|July 19, 2006
FDA perspective on trials with interim efficacy evaluationsRobert Temple
Clinical Trials (London, England)|August 13, 2011
Translating study results to labelingRobert Temple
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinical Trials (London, England)|October 7, 2011
A regulator's view of comparative effectiveness researchRobert Temple
Accountability in Research|January 1, 1996
Problems in interpreting active control equivalence trialsRobert Temple
Biomarkers in Medicine|May 19, 2010
Complexities in drug trials: enrichment, biomarkers and surrogates. Interview with Robert TempleRobert Temple
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Cancer chemoprevention--the cardiovascular modelRobert Temple
Statistics in Medicine|September 27, 2002
Policy developments in regulatory approvalRobert Temple
Molecular Interventions|December 24, 2004
ROBERT TEMPLE: an eye for data. InterviewRobert Temple
Clinical Trials (London, England)|November 12, 2005
How FDA currently makes decisions on clinical studiesRobert Temple
Pharmaceutical Statistics|August 27, 2021
Encouragement of subgroup assessment by the FDARobert Temple
Statistics in Medicine|July 19, 2006
FDA perspective on trials with interim efficacy evaluationsRobert Temple
Clinical Trials (London, England)|August 13, 2011
Translating study results to labelingRobert Temple
Pageof 9